| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.3M | — | -79.9% |
| R&D Expense | $19.2M | — | +2.0% |
| SG&A Expense | $10.7M | — | +13.4% |
| Operating Income | -$19.7M | — | -187.0% |
| Pre-tax Income | -$18.2M | — | -177.1% |
| Income Tax | $59K | — | -4.8% |
| Net Income | -$18.2M | — | -177.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $28.8M | +127.6% | -39.4% |
| Accounts Receivable | $646K | -67.9% | -67.0% |
| Current Assets | $353.1M | +145.3% | +307.6% |
| Total Assets | $359.4M | +137.1% | +264.8% |
| Current Liabilities | $34.0M | -27.0% | -32.2% |
| Total Liabilities | $39.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.5M | — | -21.4% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$192.8M | — | -730.1% |
| Financing Cash Flow | $234.5M | — | — |
| Free Cash Flow | -$25.5M | — | -20.7% |
| -46.3% |
| Stockholders' Equity | $319.9M | +223.1% | +1177.3% |